MedPath

Coramed Technologies, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Trauma Equivalency Study of the CORA® and TEG® 5000 Systems

Completed
Conditions
Trauma
First Posted Date
2015-04-03
Last Posted Date
2016-01-27
Lead Sponsor
Coramed Technologies LLC
Target Recruit Count
325
Registration Number
NCT02408029
Locations
🇺🇸

Indiana School of Medicine South Bend Notre Dame Campus, South Bend, Indiana, United States

🇺🇸

Oregon Health and Science University, Portland, Oregon, United States

🇺🇸

University of Texas Health Science Center at Houston, Houston, Texas, United States

Equivalency Study of the TEG and CORA Hemostasis Systems

Completed
Conditions
Heart Disease
Focus is on Testing Performance of CORA Hemostasis System.
First Posted Date
2013-02-13
Last Posted Date
2013-12-17
Lead Sponsor
Coramed Technologies LLC
Target Recruit Count
465
Registration Number
NCT01790386
Locations
🇺🇸

Medstar Health Research Institute - Washington Hospital Center, Washington, District of Columbia, United States

🇺🇸

Sinai Center for Thrombosis Research, Sinai Hospital, Baltimore, Maryland, United States

🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.